Next Article in Journal
Tailored Stationary Phases for Continuous Electro-Chromatographic Separation of APIs
Previous Article in Journal
Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

In Vitro-In Silico Tools to Identify Biorelevant Dissolution Specifications for the Selected Poorly-Soluble Model Drugs

Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 702; https://doi.org/10.3797/scipharm.cespt.8.PPAT13
Submission received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010

Abstract

Introduction: The most commonly used drug physicochemical property to access its in vivo performance is in vitro dissolution of a drug product.

Share and Cite

MDPI and ACS Style

GRBIC, S.; PAROJCIC, J.; DJURIC, Z. In Vitro-In Silico Tools to Identify Biorelevant Dissolution Specifications for the Selected Poorly-Soluble Model Drugs. Sci. Pharm. 2010, 78, 702. https://doi.org/10.3797/scipharm.cespt.8.PPAT13

AMA Style

GRBIC S, PAROJCIC J, DJURIC Z. In Vitro-In Silico Tools to Identify Biorelevant Dissolution Specifications for the Selected Poorly-Soluble Model Drugs. Scientia Pharmaceutica. 2010; 78(3):702. https://doi.org/10.3797/scipharm.cespt.8.PPAT13

Chicago/Turabian Style

GRBIC, S., J. PAROJCIC, and Z. DJURIC. 2010. "In Vitro-In Silico Tools to Identify Biorelevant Dissolution Specifications for the Selected Poorly-Soluble Model Drugs" Scientia Pharmaceutica 78, no. 3: 702. https://doi.org/10.3797/scipharm.cespt.8.PPAT13

Article Metrics

Back to TopTop